Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
|
Mid-range Performer
1126.7000
-10.10
(
-0.89
%)
NSE
Oct 14, 2025
14:59 PM
25.02% Fall from 52W High
Volume:
809.2K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
10 Feb 2025
1126.70
-0.89%
Result Update:Aurobindo Pharma
Buy:
Aurobindo Pharma Ltd.
by
Axis Direct
Target: 1500 | Upside : 33.1%
Target
Axis Direct
We maintain our BUY recommendation on Aurobindo Pharma with a target price of Rs 1,500/share
Aurobindo Pharma Ltd. is trading
above its 100 day SMA
of 1110.2
More from Aurobindo Pharma Ltd.
Recommended
Market trades lower, Kernex Microsystems receives RDSO approval for Kavach System 4.0
Trendlyne Marketwatch |
14 Oct 2025, 02:43PM
IPO market cools: LG Electronics, Canara Robeco, plus seven listings, and a new issue
|
13 Oct 2025, 04:01PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020